Convey Health Solutions Holdings Inc (CNVY) Stock Analyst Earnings Estimates
NYSE:CNVY - New York Stock Exchange, Inc. - US21258C1080 - Common Stock - Currency: USD
Full estimates are only available for subscribed users, you can see which data is available below.
Subscribed users also see more surprise data, now it is restricted to 4 quarters.
Examples of complete estimate data are available for MSFT and AAPL.
Registered users have access to more data. Please register or login for additional estimates and surprises .
| 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | 2025 | 2026 | ||
|---|---|---|---|---|---|---|---|---|---|
| Revenue YoY % growth | 221.153M | 282.914M 27.93% | 337.596M 19.33% | 409.794M 21.39% | 475.775M 16.10% | 546.829M 14.93% | 619.297M 13.25% | 715.397M 15.52% | |
| EBITDA YoY % growth | 15.117M | 52.606M 247.99% | 51.913M -1.32% | 80.04M 54.18% | 95.991M 19.93% | 113.106M 17.83% | 131.823M 16.55% | 156.709M 18.88% | |
| EBIT YoY % growth | -7.43M | 24.574M 430.74% | 21.433M -12.78% | 36.414M 69.90% | 56.818M 56.03% | 74.601M 31.30% | 105.074M 40.85% | 150.955M 43.67% | |
| Operating Margin | -3.36% | 8.69% | 6.35% | 8.89% | 11.94% | 13.64% | 16.97% | 21.10% | |
| EPS YoY % growth | N/A | N/A | N/A | 0.25 406.25% | 0.44 75.00% | 0.70 60.93% | 1.16 64.67% | 1.95 67.97% |
All data in USD
| Q3 / 22 | Q4 / 22 | Q1 / 23 | Q2 / 23 | Q3 / 23 | Q4 / 23 | |
|---|---|---|---|---|---|---|
| EPS Q2Q % growth | 0.09 83.60% | 0.15 1,430.00% | 0.04 278.50% | 0.07 147.36% | 0.11 16.67% | 0.21 36.67% |
| Revenue Q2Q % growth | 100.068M 21.43% | 119.498M 22.81% | 106.82M 10.46% | 104.321M 16.19% | 116.28M 16.20% | 146.37M 22.49% |
| EBITDA Q2Q % growth | 22.175M -30.36% | 29.065M -29.39% | 14.994M 35.63% | 21.42M 46.37% | 24.582M 10.86% | 37.944M 30.55% |
| EBIT Q2Q % growth | 10.803M 17.75% | 17.779M 66.45% | 7.508M 167.86% | 8.924M 439.19% | 14.076M 30.30% | 27.336M 53.76% |
All data in USD
| Period | Reported | Estimate | Difference | Surprise |
|---|---|---|---|---|
| Q2 2022 Q2Q % growth | -0.14 33.33% | 0.04 | -0.18 | -492.16% |
| Q1 2022 Q2Q % growth | -0.02 | 0.01 | -0.03 | -296.08% |
| Q4 2021 Q2Q % growth | 0.01 | 0.07 | -0.06 | -84.92% |
| Q3 2021 Q2Q % growth | 0.05 | 0.01 | 0.04 | 390.20% |
| Q2 2021 Q2Q % growth | -0.21 | -0.07 | -0.14 | -180.76% |
| Period | Reported | Estimate | Difference | Surprise |
|---|---|---|---|---|
| Q2 2022 Q2Q % growth | 89.782M 19.31% | 90.901M | -1.119M | -1.23% |
| Q1 2022 Q2Q % growth | 96.708M 17.04% | 90.935M | 5.773M | 6.35% |
| Q4 2021 Q2Q % growth | 97.306M 11.74% | 98.989M | -1.683M | -1.70% |
| Q3 2021 Q2Q % growth | 82.411M 18.53% | 81.485M | 926.464K | 1.14% |
| Q2 2021 Q2Q % growth | 75.248M 22.23% | 73.402M | 1.846M | 2.51% |
| Q1 2021 Q2Q % growth | 82.631M 27.63% | % |
| Next Q (1 month) | Next Q (3 month) | Next Year (1 month) | Next Year (3 month) | |
|---|---|---|---|---|
| EPS | N/A | N/A | N/A | N/A |
| Revenue | N/A | N/A | N/A | N/A |